Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
NUVB is expected to report earnings to -15 cents per share on August 06
Q2'25
Est.
$-0.16
Q1'25
Missed
by $0.01
Q4'24
Missed
by $0.01
Q3'24
Missed
by $0.01
Q2'24
Missed
by $1.83
The last earnings report on May 07 showed earnings per share of -15 cents, missing the estimate of -15 cents. With 2.94M shares outstanding, the current market capitalization sits at 738.37M.